2001
DOI: 10.1006/cyto.2000.0808
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin (Il-)15 Has Less Activity Than Il-2 to Promote Type 2 Cytokine Predominance in Tumour-Associated Mononuclear Cells From Lung Cancer Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2002
2002
2013
2013

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…Structurally similar to IL-2, IL-15 facilitates CD8+ memory T-lymphocyte survival and stimulates proliferation of natural killer cells, dependent on IL-15RA, in the tumor environment (42, 43). Adjuvant IL-15 therapy has been shown to result in tumor regression in a murine lung tumor model (44), underscoring the importance of examining polymorphisms in the IL15 gene.…”
Section: Discussionmentioning
confidence: 99%
“…Structurally similar to IL-2, IL-15 facilitates CD8+ memory T-lymphocyte survival and stimulates proliferation of natural killer cells, dependent on IL-15RA, in the tumor environment (42, 43). Adjuvant IL-15 therapy has been shown to result in tumor regression in a murine lung tumor model (44), underscoring the importance of examining polymorphisms in the IL15 gene.…”
Section: Discussionmentioning
confidence: 99%
“…IL‐15 appears to enhance both Th1 responses by increasing IFN‐γ production from NK and T cells [13,16,23], and Th2 responses augmenting IL‐5 production [15,23]. However, IL‐15 appears to contribute to the deviation of type 1/type 2 cytokine balance to type 1 predominance [24]. Recently, the ability of IL‐15 to augment the local T‐cell response to Mycobacterium leprae [23] and to enhance immune functions during HIV infection, restoring IL‐12 production [25], has been described.…”
Section: Introductionmentioning
confidence: 99%